Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187768 · ClinicalTrials.gov registry record
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 29
- Enrollment target
NCT04187768: Completed study, sponsored by Indiana University.
NCT04187768 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04187768 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with non small cell lung cancer
Primary Outcome
change in MDSCs before and after treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2022-06-13 |
What the finished NCT04187768 record still lists
NCT04187768 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04187768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04187768 about?
NCT04187768 is a clinical study titled "Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer". This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with no...
What is the current status of trial NCT04187768?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2019-11-26. Estimated completion is 2022-06-13.
Who is sponsoring clinical trial NCT04187768?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI